-
Antiphospholipid antibodies and vascular thrombosis in patients with severe forms of COVID-19 [Elektronski vir]Zlatković Švenda, Mirjana ...Antiphospholipid antibodies (aPLA) are a laboratory criterion for the classification of antiphospholipid syndrome (APS) and are known to cause clinical symptoms such as vascular thrombosis or ... obstetric complications. It is suggested that aPLA may be associated with thromboembolism in severe COVID-19 cases. Therefore, we aimed to combine clinical data with laboratory findings of aPLA at four time points (admission, worsening, discharge, and 3-month follow-up) in patients hospitalized with COVID-19 pneumonia. In 111 patients with COVID-19 pneumonia, current and past history of thrombosis and pregnancy complications were recorded. Nine types of aPLA were determined at four time points: anticardiolipin (aCL), anti-β2-glycoprotein I (anti- β2GPI), and antiphosphatidylserine/prothrombin (aPS/PT) of the IgM, IgG, or IgA isotypes. During hospitalization, seven patients died, three of them due to pulmonary artery thromboembolism (none were aPLA positive). Only one of the five who developed pulmonary artery thrombosis was aPLA positive. Out of 9/101 patients with a history of thrombosis, five had arterial thrombosis and none were aPLA positive at admission and follow-up; four had venous thrombosis, and one was aPLA positive at all time points (newly diagnosed APS). Of these 9/101 patients, 55.6% were transiently aPLA positive at discharge only, compared to 26.1% without a history of thrombosis (p = 0.041). Patients with severe forms of COVID-19 and positive aPLA should receive the same dose and anticoagulant medication regimen as those with negative aPLA because those antibodies are mostly transiently positive and not linked to thrombosis and fatal outcomes.Source: Biomedicines [Elektronski vir]. - ISSN 2227-9059 (Vol. 11, iss. 12, [article no.] 3117, 2023, str. 1-13)Type of material - e-article ; adult, seriousPublish date - 2023Language - englishCOBISS.SI-ID - 173528835
Author
Zlatković Švenda, Mirjana |
Ovuka, Milica |
Ogrič, Manca |
Čučnik, Saša |
Žigon, Polona, 1978- |
Radivčev, Aleksandar |
Zdravković, Marija |
Radunović, Goran
Topics
COVID-19 |
antiphospholipid syndrome |
vascular thrombosis |
antiphospholipid antibodies |
anticardiolipin antibodies (aCL) |
anti-β2-glycoprotein I antibodies (anti-β2GPI) |
anti-phosphatidylserine-prothrombin (aPS/PT) antibodies |
COVID-19 |
antifosfolipidni sindrom |
vaskularna tromboza |
antifosfolipidna protitelesa |
antikardiolipinska protitelesa (aCL) |
protitelesa proti β2-glikoproteinu I (anti-β2GPI) |
protitelesa proti fosfatidilserin-protrombinu (aPS/PT)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Zlatković Švenda, Mirjana | |
Ovuka, Milica | |
Ogrič, Manca | 38271 |
Čučnik, Saša | 16362 |
Žigon, Polona, 1978- | 24206 |
Radivčev, Aleksandar | |
Zdravković, Marija | |
Radunović, Goran |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.